Drug Safety, Medical Device, And Laboratory Regulation
US Congress 116th Congress
Allowing Greater Access to Safe and Effective Contraception Act [S.930]
Permits health savings accounts, medical savings accounts, and employer reimbursements for medications to be used for over-the-counter drugs. The bill also removes the limit on employee contributions to flexible spending accounts offered under specified health plans established pursuant to a pretax salary reduction agreement with an employer (i.e., cafeteria plans). Further, the bill requires the Food and Drug Administration to give priority review, at no cost, to applications for modifications to already-approved contraceptive drugs that are intended
(continued...)
S.930: Allowing Greater Access to Safe and Effective Contraception Act
Sponsored by: Sen. Cory Gardner
Read Twice And Referred To The Committee On Finance. on 03/28/2019
Henrietta Lacks Enhancing Cancer Research Act of 2019 [HB-1966]
Requires the Government Accountability Office to complete a study reviewing how federal agencies address barriers to participation in federally-funded cancer clinical trials by individuals from underrepresented populations and provide recommendations for addressing such barriers.
HB-1966: Henrietta Lacks Enhancing Cancer Research Act of 2019
Sponsored by: Rep. Raul Grijalva
Became Public Law No: 116-291. on 01/05/2021
Henrietta Lacks Enhancing Cancer Research Act of 2019 [S.946]
Requires the Government Accountability Office to complete a study reviewing how federal agencies address barriers to participation in federally-funded cancer clinical trials by individuals from underrepresented populations and provide recommendations for addressing such barriers.
S.946: Henrietta Lacks Enhancing Cancer Research Act of 2019
Sponsored by: Sen. Susan Collins
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 03/28/2019
HR-242: Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.
Sponsored by: Rep. Gus Bilirakis
Referred To The Subcommittee On Health. on 03/19/2019
You have voted HR-242: Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases..
Horseracing Integrity and Safety Act of 2020 [HB-1754]
Recognizes the Horseracing Integrity and Safety Authority for purposes of developing and implementing a horseracing anti-doping and medication control program and a racetrack safety program. The authority shall establish an anti-doping and medication control standing committee and a racetrack safety standing committee to provide guidance to the authority on the development and maintenance of the programs. The Federal Trade Commission (FTC) shall have oversight over the authority. The authority shall submit to the FTC any proposed rule, standard,
(continued...)
HB-1754: Horseracing Integrity and Safety Act of 2020
Sponsored by: Rep. Sean Maloney
Received In The Senate. on 09/30/2020
Short on Competition Act [S.844]
A bill to allow for expedited approval of generic prescription drugs and temporary importation of prescription drugs in the case of marginally competitive drug markets and drug shortages.
S.844: Short on Competition Act
Sponsored by: Sen. Chuck Grassley
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 03/14/2019
Marijuana Data Collection Act [HB-1587]
Requires the Department of Health and Human Services, in coordination with the Department of Justice, the Department of Labor, and relevant state agencies, to enter into an arrangement with the National Academy of Sciences in order to study the effects of marijuana legalization in states for medicinal or non-medicinal use.
HB-1587: Marijuana Data Collection Act
Sponsored by: Rep. Sean Maloney
Referred To The Subcommittee On Crime, Terrorism, And Homeland Security. on 04/08/2019
Orange Book Transparency Act of 2019 [HB-1503]
To amend the Federal Food, Drug, and Cosmetic Act regarding the list under section 505(j)(7) of the Federal Food, Drug, and Cosmetic Act, and for other purposes.
HB-1503: Orange Book Transparency Act of 2019
Sponsored by: Rep. Janice Schakowsky
Became Public Law No: 116-290. on 01/05/2021
Purple Book Continuity Act of 2019 [HB-1520]
Provides continuing FY2021 appropriations to federal agencies through December 28, 2020. It is known as a continuing resolution (CR) and prevents a government shutdown that would otherwise occur if the FY2021 appropriations bills have not been enacted when the existing CR expires on December 21, 2020.
HB-1520: Purple Book Continuity Act of 2019
Sponsored by: Rep. Yvette Clarke
Became Public Law No: 116-246. (txt | Pdf) on 12/22/2020
Affordable Insulin Act of 2019 [HB-1478]
To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe insulin by wholesale distributors, pharmacies, and individuals.
HB-1478: Affordable Insulin Act of 2019
Sponsored by: Sen. Peter Welch
Referred To The Subcommittee On Health. on 03/01/2019
Medicare for All Act of 2019 [HB-1384]
Establishes a national health insurance program that is administered by the Department of Health and Human Services (HHS). Among other requirements, the program must (1) cover all U.S. residents; (2) provide for automatic enrollment of individuals upon birth or residency in the United States; and (3) cover items and services that are medically necessary or appropriate to maintain health or to diagnose, treat, or rehabilitate a health condition, including hospital services, prescription drugs, mental health and substance abuse treatment, dental and
(continued...)
HB-1384: Medicare for All Act of 2019
Sponsored by: Rep. Raul Grijalva
Subcommittee Hearings Held. on 12/10/2019